NO145058C - Analogifremgangsmaate til fremstilling av terapeutisk virksomme imidazolderivater - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk virksomme imidazolderivater

Info

Publication number
NO145058C
NO145058C NO760783A NO760783A NO145058C NO 145058 C NO145058 C NO 145058C NO 760783 A NO760783 A NO 760783A NO 760783 A NO760783 A NO 760783A NO 145058 C NO145058 C NO 145058C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically effective
analogy procedure
imidazold
derivatives
Prior art date
Application number
NO760783A
Other languages
English (en)
Norwegian (no)
Other versions
NO145058B (no
NO760783L (OSRAM
Inventor
Keith A M Walker
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO760783L publication Critical patent/NO760783L/no
Publication of NO145058B publication Critical patent/NO145058B/no
Publication of NO145058C publication Critical patent/NO145058C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO760783A 1975-07-28 1976-03-05 Analogifremgangsmaate til fremstilling av terapeutisk virksomme imidazolderivater NO145058C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59961875A 1975-07-28 1975-07-28

Publications (3)

Publication Number Publication Date
NO760783L NO760783L (OSRAM) 1977-01-31
NO145058B NO145058B (no) 1981-09-21
NO145058C true NO145058C (no) 1982-01-04

Family

ID=24400359

Family Applications (1)

Application Number Title Priority Date Filing Date
NO760783A NO145058C (no) 1975-07-28 1976-03-05 Analogifremgangsmaate til fremstilling av terapeutisk virksomme imidazolderivater

Country Status (7)

Country Link
BE (1) BE844516A (OSRAM)
DK (1) DK158943C (OSRAM)
ES (1) ES450204A1 (OSRAM)
FI (1) FI64584C (OSRAM)
NO (1) NO145058C (OSRAM)
SE (1) SE422681B (OSRAM)
ZA (1) ZA764536B (OSRAM)

Also Published As

Publication number Publication date
NO145058B (no) 1981-09-21
DK158943B (da) 1990-08-06
BE844516A (fr) 1977-01-26
NO760783L (OSRAM) 1977-01-31
ES450204A1 (es) 1977-11-16
SE7602509L (sv) 1977-01-29
FI760423A7 (OSRAM) 1977-01-29
FI64584C (fi) 1983-12-12
ZA764536B (en) 1978-03-29
FI64584B (fi) 1983-08-31
DK158943C (da) 1990-12-31
SE422681B (sv) 1982-03-22
DK81276A (da) 1977-01-29

Similar Documents

Publication Publication Date Title
SE431088B (sv) Forfarande for framstellning av terapeutiskt verksamma benshydrylsulfinylderivat
NO147025C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme pyridinyl-2(1h)-pyridinoner
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
SE433208B (sv) Forfarande for framstellning av fenoletrar
NO146200C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 16-oksygenerte prostansyrederivater
NO145691C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme decapeptidamider
NO143796C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme piperazinyliminorifamyciner
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
NO144848C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO150081C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme derivater av perhydro-aza-heterocykler
NO142303C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
SE427839B (sv) Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider
NO150279C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme benzopyranderivater
NO144604C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme histidinderivater
NO142907C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme fenylalkylaminer
NO144741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
NO142218C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme aminderivater
NO153221C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 6-metoksy-alfa-karboksypenicilliner.
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer